SCHEMBL22315788

SCHEMBL22315788

CC/C=C\C/C=C\C/C=C\CC1NC1C/C=C\C/C=C\CCC(=O)NC1CC1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CNR2 P34972 7/20 0.74
▸ CNR1 P21554 5/20 0.74
▸ ALDH1A1 P00352 8/20 0.56
▸ MAPT P10636 5/20 0.56
▸ KMT2A Q03164 3/20 0.56
▸ MEN1 O00255 2/20 0.56
▸ HPGD P15428 2/20 0.56
▸ FAAH O00519 1/20 0.47
▸ CYP19A1 P11511 3/20 0.44
▸ PPARG P37231 3/20 0.44
▸ OXER1 Q8TDS5 3/20 0.44
▸ RXRA P19793 2/20 0.44
▸ FFAR1 O14842 2/20 0.44
▸ F7 P08709 3/20 0.42
▸ F3 P13726 3/20 0.42
▸ PTGS1 P23219 2/20 0.42
▸ PPARD Q03181 2/20 0.42
▸ PPARA Q07869 2/20 0.42
▸ ADORA3 P0DMS8 1/20 0.42
▸ KDM4E B2RXH2 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5015382 0.85 CNR2 (0.71) CNR2CNR1ALDH1A1MAPTKMT2A
SCHEMBL5015349 0.85 CNR2 (0.71) CNR2CNR1ALDH1A1MAPTKMT2A
SCHEMBL22315786 0.85 CNR2 (0.73) CNR2CNR1ALDH1A1MAPTKMT2A
SCHEMBL20840229 0.85 CNR2 (1.00) CNR2CNR1ALDH1A1MAPTKMT2A
SCHEMBL15606927 0.84 CNR2 (0.71) CNR2CNR1ALDH1A1MAPTKMT2A
SCHEMBL15526152 0.84 CNR2 (0.71) CNR2CNR1ALDH1A1MAPTKMT2A
SCHEMBL12555962 0.81 ALDH1A1 (0.81) CNR2CNR1ALDH1A1MAPTKMT2A
SCHEMBL22301831 0.81 ALDH1A1 (0.60) CNR2CNR1ALDH1A1MAPTKMT2A
SCHEMBL22301830 0.78 CNR2 (0.86) CNR2CNR1ALDH1A1MAPTKMT2A
SCHEMBL18885368 0.75 ALDH1A1 (0.70) CNR2CNR1ALDH1A1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200247776-A1 DOCOSAHEXAENOIC ACID ENDOCANNABINOID EPOXIDE DERIVATIVE COMPOSITIONS THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS 2020-08-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200247776-A1 DOCOSAHEXAENOIC ACID ENDOCANNABINOID EPOXIDE DERIVATIVE COMPOSITIONS ALOX5, ALOX15, PTGER1 CNR2 22/4885CNR1 31/4885ALDH1A1 2485/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback